Featured Videos |View More
Video
Tumor-Treating Fields for Glioblastoma and Other Brain Tumors
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
Video
Improving Pediatric Drug Development
Andrew M. Atz, M.D., chair of the Department of Pediatrics at the Medical University of South Carolina, outlines the problem about the efficacy and safety of drugs in children.
Video
Resection of Pineocytomas Offers Symptom Relief
Sunil J. Patel, M.D., chair of the Department of Neurosurgery at MUSC, is one of a handful of surgeons in the world who resects symptomatic pineal cysts.
Video
MUSC Health orthopaedic surgeon Josef K. Eichinger, M.D., discusses the case of a 13-year-old baseball player with left elbow pain who was successfully treated with elbow arthroscopy.
Video
Reanimating the Paralyzed Face
Samuel L. Oyer, M.D., discusses a technique used in facial reanimation surgery — masseter-to-facial nerve transfer — that can restore a patient’s ability to smile.
Video
New Rule-Out Test for Lung Cancer Increases Diagnostic Precision
Gerard A. Silvestri, M.D., a lung cancer pulmonologist at MUSC, led a study that shows that a new biomarker is 98 percent effective at distinguishing benign from malignant lung nodules.
Video
Instagrams of the Immune System - Predict Responses to Immunotherapy
Carsten Krieg, Ph.D.,discusses how “Instagrams of the immune system,” captured by a new technology, made it possible to identify biomarkers of response to immunotherapy in patients with melanoma.
Video
Edward C. Jauch, M.D., interim chair of the Department of Emergency Medicine at the Medical University of South Carolina, discusses what’s new in this update regarding thrombolytic therapy, endovascular surgery, in-hospital care, credentialing and more.
Video
Optimizing Care for Children with Vascular Anomalies
Lara Wine Lee, M.D, discusses types of vascular anomalies in children, their medical and/or surgical management, the goals of therapy and the multidisciplinary approach taken to their treatment at MUSC Children’s Health.
Featured Documents |View More
Document
TELL-TALE BLOOD Liquid Biopsy offers a Useful Diagnostic Companion for Targeted Therapies
Conventional biopsies are invasive, costly, and sometimes impossible to conduct, but they yield valuable information other methods were unable to provide—until now.
Document
Testing Stem Cells as Possible Treatment for Heart Failure
Stem cells are being tested at the Medical University of South Carolina as a possible treatment for heart failure with a preserved ejection fraction, or HFpEF.
Document
Genomics screening can improve the odds for some cancer patients, potentially identifying mutations associated with cancer subtypes for which targeted therapies exist or are in development.
MUSC Health, the clinical enterprise of the Medical University of South Carolina (MUSC), is dedicated to the pursuit of changing what’s possible in health care. Nationally recognized for its innovation, patient- and family-centered care, and quality outcomes, this integrated health care system is accessible at the downtown Charleston campus and through more than 100 outreach locations, clinical affiliations with numerous health care partners, and a robust telehealth network. MUSC Health sees more than one million patient encounters annually, and its specialized care teams consistently rank among the best in the country. MUSC Health delivers transformational care shaped by world-class clinicians, health scientists, and educators who provide leading-edge care, while developing the next generation of innovative health care leaders.
